The U.S. government awarded a firm fixed-price delivery order contract valued at $27,200.00 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, with a completion date of January 3, 2025, is for XPCOV2/FLU/RSV-10 products and services, which are likely COVID-19, influenza, and respiratory syncytial virus diagnostic tests and related items. Cepheid has been awarded multiple federal contracts and indefinite delivery vehicles (IDVs) by agencies such as the Department of Veterans Affairs, Defense Logistics Agency, and Department of Health and Human Services to provide diagnostic testing equipment, reagents, consumables, and support services. This particular award does not have a set-aside designation, as Cepheid is often the prime contractor and original equipment manufacturer for these types of medical diagnostic products and services.
Generated 3/27/25, 9:53 AM